About Us
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries.
To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com
Schedule a Meeting
External Links
Resources
Team Members
Patrick Melvin
VP, Clinical Development and Head of Novel and Emerging Therapies
Peter Robinson
VP, Strategic Alliances and Head of Cell and Gene Therapy Consortium
